GSK-2647544

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGSK-2647544
Drug Alias Name2647544GSK-2647544
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipoprotein-associated phospholipase A2 inhibitors
TargetsLipoprotein-associated phospholipase A2
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A